Crane (CR)

NYSEIndustrialsIndustrial - MachinerySnapshot 2026-10-23

$182.89-3.26%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Crane’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.1%

+10% or more+5%0%−5%−10% or less

7.83 → 7.84 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	733.01M
EPS	—	1.777
FY 2026 · Annual
Revenue	—	2.89B
EPS	$6.85–$7.05non-GAAP	7.031
FY 2027 · Annual
Revenue	—	3.05B
EPS	—	7.838

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Cash from operations improves toward break-even	Cash flow is improving, reducing negative cash from operations.	Intact	Cash from operations remains deeply negative or worsens	Cash from operations: $122.3M FY2026-Q2; GAAP. Published target: Cash from operations improves from -$29.5M toward zero. Target period is not explicitly aligned with this observation. Source published Jul 31, 2026122,300,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Dividend per share grows to about $0.26 per quarter	Crane grows earnings steadily with EPS guidance raised to about $6.75 for 2026.	Intact	Dividend per share fails to grow to $0.26	Dividend per share: $0.26 per share FY2026-Q2; GAAP. Published target: >= $0.26 USD per share. Target period is not explicitly aligned with this observation. Source published Jul 31, 20260.255 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 59071e99-31fc-4ef6-9d8b-e0fbb4423cdd. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS reaches at least $6.65 in fiscal 2026	A primary condition in Crane's published investment case. The stated target is >= $6.65 USD per share.	Intact	EPS falls below $6.65 in FY26	Diluted EPS: $1.63 per share FY2026-Q2; GAAP. Published target: >= $6.65 USD per share. Target period is not explicitly aligned with this observation. Source published Jul 31, 20261.63 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 59071e99-31fc-4ef6-9d8b-e0fbb4423cdd. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Management raised full year adjusted EPS guidance from $6.65-$6.85 in 2026-Q1 to $6.85-$7.05 in 2026-Q2, reflecting strong performance and acquisition contributions. The trajectory is delivering with EPS guidance increases aligned with reported growth. Delivery assessment Oct 24, 2026
Revenue grows at least 15% year over year	Revenue grew nearly 25% year over year last quarter.	Intact	Revenue growth falls below 15% YoY	Revenue growth: 25.55% FY2026-Q2; GAAP. Published target: >= 15% YoY. Target period is not explicitly aligned with this observation. Source published Jul 31, 202625.554401 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 59071e99-31fc-4ef6-9d8b-e0fbb4423cdd. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. Management raised full year adjusted EPS guidance from $6.65-$6.85 in 2026-Q1 to $6.85-$7.05 in 2026-Q2, reflecting strong performance and acquisition contributions. The trajectory is delivering with EPS guidance increases aligned with reported growth. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$7.84

$7.63 → $7.84 · observed estimates

FY2027 revenue$3.05B

$3.04B → $3.05B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$7.63	$3,035,439,870	10 / 10
2026-07-25	$7.63	$3,035,439,870	10 / 10
2026-07-26	$7.68	$3,038,384,071	7 / 7
2026-07-27	$7.63	$3,035,439,870	10 / 10
2026-07-28	$7.63	$3,035,439,870	10 / 10
2026-07-29	$7.68	$3,038,384,071	7 / 7
2026-07-30	$7.68	$3,038,384,071	7 / 7
2026-07-31	$7.79	$3,047,621,571	7 / 7
2026-08-01	$7.79	$3,047,621,571	7 / 7
2026-08-02	$7.82	$3,052,612,190	9 / 9
2026-08-03	$7.82	$3,052,263,711	7 / 7
2026-08-04	$7.82	$3,052,612,190	9 / 9
2026-08-05	$7.82	$3,052,612,190	9 / 9
2026-08-06	$7.78	$3,046,696,410	10 / 10
2026-08-07	$7.78	$3,045,729,345	7 / 7
2026-08-08	$7.78	$3,046,696,410	10 / 10
2026-08-09	$7.78	$3,046,696,410	10 / 10
2026-08-10	$7.78	$3,046,696,410	10 / 10
2026-08-11	$7.78	$3,045,729,345	7 / 7
2026-08-12	$7.80	$3,050,181,510	10 / 10
2026-08-13	$7.80	$3,050,181,510	10 / 10
2026-08-14	$7.78	$3,045,729,345	7 / 7
2026-08-15	$7.78	$3,045,729,345	7 / 7
2026-08-16	$7.78	$3,045,729,345	7 / 7
2026-08-17	$7.78	$3,045,729,345	7 / 7
2026-08-18	$7.78	$3,045,729,345	7 / 7
2026-08-19	$7.78	$3,045,729,345	7 / 7
2026-08-20	$7.78	$3,045,729,345	7 / 8
2026-08-21	$7.80	$3,049,601,674	7 / 8
2026-08-22	$7.80	$3,049,601,674	7 / 8
2026-08-23	$7.80	$3,049,601,674	7 / 8
2026-08-24	$7.80	$3,049,601,674	7 / 8
2026-08-25	$7.80	$3,049,601,674	7 / 8
2026-08-26	$7.80	$3,049,601,674	7 / 8
2026-08-27	$7.80	$3,049,601,674	7 / 8
2026-08-28	$7.80	$3,049,601,674	7 / 8
2026-08-29	$7.80	$3,049,601,674	7 / 8
2026-08-30	$7.80	$3,049,601,674	7 / 8
2026-08-31	$7.80	$3,049,601,674	7 / 8
2026-09-01	$7.80	$3,049,601,674	7 / 8
2026-09-02	$7.82	$3,049,359,692	7 / 8
2026-09-03	$7.82	$3,049,359,692	7 / 8
2026-09-04	$7.82	$3,049,359,692	7 / 8
2026-09-05	$7.82	$3,049,359,692	7 / 8
2026-09-06	$7.82	$3,049,359,692	7 / 8
2026-09-07	$7.82	$3,049,359,692	7 / 8
2026-09-08	$7.82	$3,049,359,692	7 / 8
2026-09-09	$7.82	$3,049,359,692	7 / 8
2026-09-10	$7.82	$3,049,359,692	7 / 8
2026-09-11	$7.82	$3,049,359,692	7 / 8
2026-09-12	$7.82	$3,049,359,692	7 / 8
2026-09-13	$7.82	$3,049,359,692	7 / 8
2026-09-14	$7.82	$3,049,359,692	7 / 8
2026-09-15	$7.82	$3,049,359,692	7 / 8
2026-09-16	$7.82	$3,049,360,048	7 / 8
2026-09-17	$7.83	$3,048,153,034	7 / 8
2026-09-18	$7.83	$3,048,153,034	7 / 8
2026-09-19	$7.83	$3,048,153,034	7 / 8
2026-09-20	$7.83	$3,048,153,034	7 / 8
2026-09-21	$7.83	$3,048,153,034	7 / 8
2026-09-22	$7.83	$3,048,153,034	7 / 8
2026-09-23	$7.83	$3,048,153,034	7 / 8
2026-09-24	$7.83	$3,048,153,034	7 / 8
2026-09-25	$7.83	$3,048,153,034	7 / 8
2026-09-26	$7.83	$3,048,153,034	7 / 8
2026-09-27	$7.83	$3,048,153,034	7 / 8
2026-09-28	$7.83	$3,048,153,034	7 / 8
2026-09-29	$7.83	$3,048,153,034	7 / 8
2026-09-30	$7.83	$3,048,153,034	7 / 8
2026-10-01	$7.83	$3,048,153,034	7 / 8
2026-10-02	$7.83	$3,048,153,034	7 / 8
2026-10-03	$7.83	$3,048,153,034	7 / 8
2026-10-04	$7.83	$3,048,153,034	7 / 8
2026-10-05	$7.83	$3,048,153,034	7 / 8
2026-10-06	$7.83	$3,048,153,034	7 / 8
2026-10-07	$7.83	$3,048,153,034	7 / 8
2026-10-08	$7.83	$3,048,153,034	7 / 8
2026-10-09	$7.83	$3,048,119,701	7 / 8
2026-10-10	$7.84	$3,048,815,982	7 / 8
2026-10-11	$7.84	$3,048,815,982	7 / 8
2026-10-12	$7.84	$3,048,815,982	7 / 8
2026-10-13	$7.84	$3,048,815,982	7 / 8
2026-10-14	$7.84	$3,048,815,982	7 / 8
2026-10-15	$7.84	$3,048,815,982	7 / 8
2026-10-16	$7.84	$3,048,815,982	7 / 8
2026-10-17	$7.84	$3,048,815,982	7 / 8
2026-10-18	$7.84	$3,048,815,982	7 / 8
2026-10-19	$7.84	$3,048,815,982	7 / 8
2026-10-20	$7.84	$3,047,460,427	7 / 8
2026-10-21	$7.84	$3,047,947,765	7 / 8
2026-10-22	$7.84	$3,047,947,765	7 / 8
2026-10-23	$7.84	$3,047,947,765	7 / 8
2026-10-24	$7.84	$3,047,947,765	7 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	8	2	0
2026-06-01	8	1	1
2026-07-01	9	1	1
2026-08-01	9	1	0
2026-09-01	9	1	0
2026-10-01	9	1	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 9 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Cash from operations improves toward break-evenCash from operations: $122.3M
Dividend per share grows to about $0.26 per quarterDividend per share: $0.26 per share
EPS reaches at least $6.65 in fiscal 2026Diluted EPS: $1.63 per share
Revenue grows at least 15% year over yearRevenue growth: 25.55%

Next proof point

Oct 27, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-23.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Crane outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

CR is a growth-oriented industrial company using acquisitions alongside core sales growth, rather than a clear turnaround or deep-value case. Its long-term thesis is intact, though confidence is medium and earnings quality is fragile.

What's priced into Crane

Valuation is described as justified, with expectations broadly aligned with the available evidence. CR trades at a modest premium to peers, while the model has low confidence and the expectations gap is slightly negative, so the valuation read is not definitive.

What the fundamentals likely do

Near term, recent performance is strong: second-quarter core sales grew, total sales rose with acquisition contributions, and management raised 2026 adjusted EPS guidance. The raised outlook and dividend growth support the multi-year case, but execution quality remains fragile and the sector backdrop is a headwind.

What Crane hinges on

A key near-term test is whether management can sustain its raised guidance; a reversal and guidance cut would also weaken credibility. The broader industrial setup depends partly on whether sector bellwethers continue to report strong results and raise guidance or instead miss and lower expectations.